Up 75%, This Biotech Could Soar Even Higher In 2026
Swiss oncology powerhouse, BeOne Medicines, has emerged as one of 2025’s top performers in a sector often plagued by volatility. Year-to-date, shares have rocketed 75%, outpacing many… Read More »Up 75%, This Biotech Could Soar Even Higher In 2026








